[LGND] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
14-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 111.17%
YoY- -99.68%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 27,995 29,267 38,185 21,619 19,521 29,648 21,192 20.41%
PBT 8,300 6,193 7,230 804 -9,644 9,571 5,826 26.63%
Tax 2,242 1,114 10,355 160 -3,881 3,694 -515 -
NP 6,058 5,079 -3,125 644 -5,763 6,608 6,341 -3.00%
Tax Rate -27.01% -17.99% -143.22% -19.90% - -38.60% 8.84% -
Total Cost 21,937 24,188 41,310 20,975 25,284 23,040 14,851 29.73%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 21.64 17.35 -8.18 2.98 -29.52 22.29 29.92 -19.44%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS 0.29 0.24 -0.15 0.03 -0.28 0.32 0.32 -6.35%
EPS Diluted 0.26 0.22 -0.15 0.03 -0.28 0.30 0.29 -7.02%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.